• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Potentially Undervalued Companies
1,971 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

0HIY

Atara Biotherapeutics
US$0.69-12.4%-76.1%US$84.5mUS$4.29PS9.4xE49.0%n/a

0HOJ

Blueprint Medicines
US$86.48-5.6%n/aUS$5.3bUS$98.86PS20.9xE66.2%n/a

R2AR34

Ultragenyx Pharmaceutical
US$23.380%n/aUS$3.5bUS$49.11PS8.1xE48.9%n/a

BM8

BioMarin Pharmaceutical
US$87.329.1%-2.9%US$17.5bUS$104.99PE103.6xE30.9%n/a

YS

YS Biopharma
US$0.891.1%-43.7%US$162.0mUS$4.29PS2.2xE56.6%n/a

TRX

Tissue Regenix Group
UK£0.610%3.4%UK£43.3mUK£1.20PS1.8xE133.0%n/a

PRTA

Prothena
US$21.99-7.1%-58.7%US$1.2bUS$66.09PS12.9xE32.2%n/a

PLRX

Pliant Therapeutics
US$13.55-7.9%-51.1%US$852.4mUS$43.00PS516.6xE-0.5%n/a

LVRL.F

CordovaCann
US$0.072-9.3%-39.8%US$8.7mn/aPE-1.8xn/an/a

BIOV.F

Swedish Orphan Biovitrum
kr25.000%-5.3%kr86.4bkr30.89PE35.9xE21.7%n/a

SNDL

SNDL
US$1.92-15.4%22.3%US$526.2mUS$3.61PB0.6xE135.8%n/a

JNJ

Johnson & Johnson
US$149.00-8.0%-10.2%US$355.7bUS$177.03PE26.7xE9.7%3.2%

VLS

Vita Life Sciences
AU$2.342.2%64.8%AU$129.9mn/aPE14.4xn/a3.8%

QIAD

Qiagen
US$41.150%-5.0%US$8.8bUS$52.91PE25.7xE11.2%n/a

0K9H

Faes Farma
€3.170.8%2.4%€988.2m€3.71PE10.8xE-1.1%4.9%

0IIM

Esperion Therapeutics
US$2.02-31.2%52.9%US$366.5mUS$7.72PS3.2xE59.2%n/a

0HNC

BioMarin Pharmaceutical
US$92.834.8%-6.1%US$17.4bUS$111.62PE103.6xE30.8%n/a

TLX

Telix Pharmaceuticals
AU$12.732.5%43.2%AU$4.3bAU$14.88PE807.3xE37.9%n/a

0XOD

UroGen Pharma
US$15.1110.1%52.2%US$515.2mUS$38.51PS6.2xE60.5%n/a

0A3M

BioNTech
US$88.30-1.7%-28.3%US$21.2bUS$114.28PE21.5xE-20.3%n/a

0ABG

Swedencare
kr61.46-8.1%134.8%kr9.8bkr68.01PE166.5xE50.4%0.4%

CU6

Clarity Pharmaceuticals
AU$2.65-4.0%268.1%AU$811.7mAU$3.30PS87.5xE47.0%n/a

2728

Teyi Pharmaceutical GroupLtd
CN¥15.531.4%-0.6%CN¥5.4bn/aPE22.4xE19.4%3.2%

603538

Ningbo Menovo Pharmaceutical
CN¥12.10-14.0%-49.9%CN¥2.8bn/aPE14.4xE33.2%1.4%
Page 81 of 83
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.